Thyroid cancer in Brazil: a descriptive study of cases reported between 2013-2020




Brazil; Epidemiology; Neoplasms; Thyroid Gland; Thyroid neoplasms.


The objective was to analyze the reported cases of thyroid cancer in Brazil, associating the variables: age group, gender, federative unit of diagnosis, year of diagnosis, detailed diagnosis, and therapeutic modality. Thus, was conducted a descriptive epidemiological study of quantitative character, using data available in the official notification bank of the Ministry of Health/Brazil, DATASUS. And because they are secondary data and in the public domain, it was not necessary to submit this study to the Research Ethics Committee. According to the period investigated, there was a total of 19.122 cases of thyroid cancer reported, 3.074 in men, equivalent to 16.08%, and 16.048 in women, with a percentage of 83.92%. Furthermore, it is possible to verify that cases of thyroid cancer in men and women had a significant increase in the period from 2018 to 2021, if compared to previous years. However, the cases in the female gender obtained an increase from 2017 to 2018 of about 39 times. It is concluded that the incidence and prevalence of thyroid cancer have increased in recent years, especially in females, and the age group 50 to 54 years was the most prevalent, obtaining 944 cases, being the highest rate in the period analyzed and among the other age groups.

Author Biography

Rubens Barbosa Rezende, Universidade Federal de São Paulo

Graduado em Biomedicina (UNIFASAR - 2017/2021), com habilitação em Patologia Clínica, Imagenologia, Citologia Oncótica, Imunologia e em Hematologia. Especialista em Imunologia Clínica, Hematologia e Citologia Oncótica pela Faculdade UniBF; e em Imagenologia pela Faculdade Unyleya. Possui MBA em Gestão de Laboratórios pela Universidade Estácio de Sá. E atualmente é pós-graduando em Biotecnologia pela Universidade Federal de São Paulo e em Microbiologia Clínica e Laboratorial pela Academia de Ciência e Tecnologia. 


Almquist, M., Johansen, D., Bjorge, T., Ulmer, H., Lindkvist, B., Stocks, T., et al. (2011). Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control, 22, 743-751, 10.1007/s10552-011-9747-2

Asano, K., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., et al. (2008). Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int. J. Canc., 122, 909-914, 10.1002/ijc.23191

Baloch, S., Baloch, M. A., Zheng, T., & Pei, X. (2020). The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J Exp Med. Apr; 250(4):271-278, 10.1620/tjem.250.271.

Bhaskaran K., et al. (2014). Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 30;384(9945):755-65.

Brasil. Ministério da Saúde. DATASUS. (2021).

Brasil. Ministério da Saúde. Fundação Nacional de Saúde. (2001). Manual de procedimentos do sistema de informações sobre mortalidade. Brasília: Funasa.

Bray, F., et al. (2017) Cancer incidence in five Continents, Vol. XI [Internet]. Lyon: International Agency for Research on Cancer.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424. 10.3322/caac.21492

Chen, G., Xu, S., Renko, K., & Derwahl, M. (2012). Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agentes. J. Clin. Endocrinol. Metab., 97, 510-520, 10.1210/jc.2011-1754

Coeli, C. M., et al. (2005). Incidence and mortality from thyroid cancer in Brazil. Arq Bras Endocrinol Metabol. 49(4):503-9.

Davies, L., & Welch, H. G. (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama-Journal Am. Med. Assoc., 295, p. 2164-2167. 10.1001/jama.295.18.2164

Diehl, A. A. (2004). Pesquisa em ciências sociais aplicadas: métodos e técnicas. Prentice Hall.

Dietrich, S., Floegel, A., Weikert, C., Pischon, T., Boeing, H., & Drogan, D. (2016). Identification of serum metabolites associated with incident hypertension in the European prospective investigation into cancer and nutrition-potsdam study. Hypertension, 68, 471-477, 10.1161/hypertensionaha.116.07292

Djiogue, S., Nwabo Kamdje, A. H., Vecchio, L., Kipanyula, M. J., Farahna, M., Aldebasi, Y., & Seke Etet, P. F. (2013). Insulin resistance and cancer: the role of insulin and IGFs. Endocr. Relat. Canc., 20, 1-17, 10.1530/erc-12-0324

Garcia, A. C., Cavalcanti, T. C., Collaço, L. M., & Graf, H. (2022). Biossinalização do câncer de tireoide. Research, Society and Development, 11(3), e41811326619.

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schunemann. J. P. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br. Med. J., 336, 924-926, 10.1136/bmj.39489.470347.AD

Hiatt, R. A., & Fireman. B. H. (1986). Serum cholesterol and the incidence of cancer in a large cohort. J. Chron. Dis., 39, 861-870.

Hsu, P. P., & Sabatini, D. M. (2008). Cancer cell metabolism: warburg and beyond. Cell, 134, 703-707, 10.1016/j.cell.2008.08.021

Ibrahim, E. Y., & Busaidy, N. L. (2017). Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer. Curr. Opin. Oncol. 29, 151–158, 10.1097/CCO.0000000000000349

Instituto Nacional de Câncer – INCA. (2021). Ministério da Saúde. Câncer de tireoide.

Jozwiak, P., Krzeslak, A., Brys, M., & Lipinska. A. (2015). Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells, Oncol. For. Rep., 33, 913-920, 10.3892/or.2014.3673

Jung, U. J., & Choi. M. S. (2014). Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci., 15, 6184-6223, 10.3390/ijms15046184

La Vecchia, C., et al. (2015). Thyroid cancer mortality and incidence: a global overview. Int J Cancer [Internet]136(9):2187-95.

Lima-Costa, M. F., & Barreto, S. M. (2003). Tipos de estudos epidemiológicos: conceitos básicos e aplicações na área do envelhecimento. Epidemiologia e Serviços de Saúde, 12(4), 189-201.

Marcello, M. A., Calixto, A. R., Martins de Almeida, J. F., Martins, M. B., Cunha, L. L., Amano Cavalari, C. A., et al. (2015). Polymorphism in LEP and LEPR may modify leptin levels and represent risk factors for thyroid câncer. Internet J. Endocrinol., 8, 10.1155/2015/173218

Martins, J. R. M., Villagelin, D. G., Carvalho, G. A., Vaisman, F., Teixeira, P. F., Scheffel, R. S., & Sgarbi, J. A. (2021). Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM). Archives of Endocrinology and Metabolism, 65(3), 368-375, 10.20945/2359-3997000000352

Milan, A., Puglisi, E., Ferrari, L., Bruno, G., Losano, I., & Veglio. F. (2014). Arterial hypertension and câncer. Int. J. Canc., 134, 2269-2277, 10.1002/ijc.28334

Mondul, A. M., Weinstein, S. J., Virtamo, J., & Albanes, D. (2011). Serum total and HDL cholesterol and risk of prostate câncer. Cancer Causes Control, 22, p. 1545-1552, 10.1007/s10552-011-9831-7

Nguyen, Q. T., Lee, E. J., Huang, M. G., Park, Y. I., Khullar, A., & Plodkowski, R. A. (2015). Diagnosis and treatment of patients with thyroid cancer. Am. Health Drug Benefits, 8, 30–40. PMC4415174

Pappa, T., & Alevizaki, M. (2014). Obesity and thyroid cancer: a clinical update. Thyroid, 24, 190-199, 10.1089/thy.2013.0232

Park, J., & Scherer. P. E. (2011). Leptin and cancer: from cancer stem cells to metastasis. Endocr. Relat. Canc., 18, 25-29, 10.1530/erc-11-0163

Pazaitou-Panayiotou, K., Panagiotou, G., Polyzos, S. A., & Mantzoros, C. S. (2016). Serum adiponectin and insulin-like growth factor 1 in predominantly female patients with thyroid cancer: association with the histologic characteristics of the tumor Endocr. Pract., 22, 68-75,10.4158/ep15814.or

Pellegriti G., et al. (2013). Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. e-965212.

Radišauskas, R., Kuzmickienė, I., Milinavičienė, E., & Everatt. R. (2016). Hypertension, serum lipids and cancer risk: a review of epidemiological evidence. Medicina, 52, 89-98, 10.1016/j.medici.2016.03.002

Rehem, R. A., Elwafa, W. A., Elwafa, R. A., & Abdel-Aziz. T. E. (2014). Study of serum leptin in well-differentiated thyroid carcinoma: correlation with patient and tumor characteristics. World J. Surg., 38, 2621-2627, 10.1007/s00268-014-2634-8

Santos, L. M., et al. (2016). Evolução temporal da mortalidade por câncer de tireoide no Brasil no período de 2000 a 2012. RBAC. 48(2):133-7.

Schlaich, M., Straznicky, N., Lambert, E., & Lambert, G. (2015). Metabolic syndrome: a sympathetic disease? Lancet Diabetes Endocrinol, 3, 148-157, 10.1016/s2213-8587(14)70033-6

Stjepanovic, N., & Capdevila, J. (2014). Multikinase inhibitors in the treatment of thyroid cancer: Specific role of lenvatinib. Biol. Targets Ther. 2014, 8, 129–139.

Strasak, A. M., Pfeiffer, R. M., Brant, L. J., Rapp, K., Hilbe, W., Oberaigner, W., et al. (2009). Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study. Ann. Oncol., 20, 1113-1120, 10.1093/annonc/mdn736

Tseng, C. H. (2014). Metformin reduces thyroid cancer risk in taiwanese patients with type 2 diabetes. PLoS One, 9 (2014), Article e109852

Tsumagari, K., Abd Elmageed, Z. Y., Sholl, A. B., Friedlander, P., Abdraboh, M., Xing, M., et al. (2015). Simultaneous suppression of the MAP kinase and NF-kappaB pathways provides a robust therapeutic potential for thyroid câncer. Canc. Lett., 368, 46-53, 10.1016/j.canlet.2015.07.011

Vaccarella S., et al. (2015). The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid [Internet]. 25(10):1127-36. 10.1089/thy.2015.0116

Weikert, S., Boeing, H., Pischon, T., Weikert, C., Olsen, A., Tjonneland, A. et al. (2008). Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am. J. Epidemiol., 167, 438-446, 10.1093/aje/kwm321

Xiao, J., Shen, C., Chu, M. J., Gao, Y. X., Xu, G. F., Huang, J. P., Xu, Q. Q., & Cai. H. (2016). Physical activity and sedentary behavior associated with components of metabolic syndrome among people in rural China. PLoS One, 11, e0147062, 10.1371/journal.pone.0147062

Yin, D. T., He, H., Yu, K., Xie, J., Lei, M., Ma, R., Li, H., Wang, Y., & Liu, Z. (2018). The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis. International journal of surgery (London, England), 57, 66–75. 10.1016/j.ijsu.2018.07.013



How to Cite

REZENDE, R. B. Thyroid cancer in Brazil: a descriptive study of cases reported between 2013-2020. Research, Society and Development, [S. l.], v. 12, n. 2, p. e6612239974, 2023. DOI: 10.33448/rsd-v12i2.39974. Disponível em: Acesso em: 3 oct. 2023.



Health Sciences